Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/ Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial
暂无分享,去创建一个
F. Raffi | J. Parienti | L. Hocqueloux | L. Bernard | Le Moal | T. Prazuck | D. Rey | C. Allavena | E. Billaud | A. Valéry | S. Sunder | M. Roncato-Sabéran | J. Esnault | M. André | V. Avettand-Fenoël